Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

This article has no abstract
Epistemonikos ID: ceb2e51040bf80f154718aa2aa28bed2ce67cd2d
First added on: Feb 06, 2025